-
Caregiving With Confidence
Be Ready for Caregiving to Change YouCaring for a loved one with cancer can change your life–often for the good.
by Deborah J. Cornwall
-
The Ways We Approach Death
Cancer often requires making difficult decisions in the face of uncertainty.
by Sue Rochman
-
Healthy Habits
Movement MeditationTai chi may provide a gentle way for cancer survivors and patients to be active.
by Kurt Ullman
-
Q&A
When Time Doesn’t HealResearcher and social worker Mary Ann Burg discusses the long-term challenges cancer survivors face and recent efforts to address these needs.
by Marci A. Landsmann
-
Sound Advice
Spring 2015vol 05 | issue 01
Staying on the job through treatments, getting organized to care for a loved one, and remaining financially solvent through cancer care -
Forward Look
Hope for a Future FamilyFertility preservation outcomes may vary with cancer diagnosis.
by Kendall K. Morgan
-
Your Cancer Guide
Living With Advanced CancerMake the most of your days despite the uncertainty that comes with metastatic disease.
by Hester Hill Schnipper
-
What Is Your Learning Style?
Understanding how you learn best can help you get the most out of your meetings with your medical team.
by Ide Mills
-
Healthy Habits
Room to ImproveMost cancer survivors don't get enough exercise.
by Alanna Kennedy-Gorman
-
Q&A
Paying Attention to DepressionPsychiatrist Michael Sharpe suggests a new approach to identifying and treating depression in cancer patients.
by Marci A. Landsmann
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona